Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04932278 · ClinicalTrials.gov registry record · NA
The Role of Osteopathic Manipulative Medicine in Recovery From Concussions
A NA study, sponsored by Michigan State University.
- Terminated
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT04932278: Clinical Trial NA study, sponsored by Michigan State University.
NCT04932278 is a NA study that was terminated before completion, run by Michigan State University. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04932278, a NA study, was terminated before completion, sponsored by Michigan State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
This project aims to study whether adding osteopathic manipulative treatment (OMT) to usual care of concussed patients will enhance their recovery.
Primary Outcome
Symptom evaluation score is a self-reported measure of the participants' post-concussion symptoms. Participants are scored on Total Number of Symptoms (ranges 0 to 22) and Symptom Severity Score (ranges 0 to 132). Higher scores represent worse outcome.
Interventions
- PROCEDURE Osteopathic manipulative treatment
- PROCEDURE Usual care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2021-09-22 |
| Est. Completion | 2025-07-10 |
| Phase | NA |
Why NCT04932278 stopped before completion
NCT04932278 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Osteopathic manipulative treatment is the first listed.
NCT04932278 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04932278 about?
NCT04932278 is a clinical study titled "The Role of Osteopathic Manipulative Medicine in Recovery From Concussions". This project aims to study whether adding osteopathic manipulative treatment (OMT) to usual care of concussed patients will enhance their recovery.
What is the current status of trial NCT04932278?
This trial is currently terminated. It is a NA study. The enrollment target is 39 participants. The study started on 2021-09-22. Estimated completion is 2025-07-10.
What interventions are being tested in trial NCT04932278?
The interventions under investigation include: Osteopathic manipulative treatment (PROCEDURE), Usual care (PROCEDURE).
Who is sponsoring clinical trial NCT04932278?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04932278's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI